Gemma Osca‐Gelis

557 total citations
13 papers, 337 citations indexed

About

Gemma Osca‐Gelis is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Gemma Osca‐Gelis has authored 13 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in Gemma Osca‐Gelis's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Gemma Osca‐Gelis is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Gemma Osca‐Gelis collaborates with scholars based in Spain, United States and France. Gemma Osca‐Gelis's co-authors include Rafael Marcos‐Gragera, Roberta De Angelis, Lesley Anderson, Morgane Mounier, Milena Sant, Hermann Brenner, Alain Monnereau, Pamela Minicozzi, Otto Visser and Marc Maynadié and has published in prestigious journals such as The Lancet Oncology, Frontiers in Immunology and Cancer Causes & Control.

In The Last Decade

Gemma Osca‐Gelis

13 papers receiving 333 citations

Peers

Gemma Osca‐Gelis
Clara Lam United States
Scott Marshall United Kingdom
Richard Mansour United States
Clara Lam United States
Gemma Osca‐Gelis
Citations per year, relative to Gemma Osca‐Gelis Gemma Osca‐Gelis (= 1×) peers Clara Lam

Countries citing papers authored by Gemma Osca‐Gelis

Since Specialization
Citations

This map shows the geographic impact of Gemma Osca‐Gelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Osca‐Gelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Osca‐Gelis more than expected).

Fields of papers citing papers by Gemma Osca‐Gelis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Osca‐Gelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Osca‐Gelis. The network helps show where Gemma Osca‐Gelis may publish in the future.

Co-authorship network of co-authors of Gemma Osca‐Gelis

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Osca‐Gelis. A scholar is included among the top collaborators of Gemma Osca‐Gelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Osca‐Gelis. Gemma Osca‐Gelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Osca‐Gelis, Gemma, Rocío Rodriguez, Albert Oriol, et al.. (2024). CD200 genotype is associated with clinical outcome of patients with multiple myeloma. Frontiers in Immunology. 15. 1252445–1252445. 1 indexed citations
2.
Rodriguez, Rocío, Gemma Osca‐Gelis, Albert Oriol, et al.. (2023). Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma. Frontiers in Immunology. 14. 1158105–1158105. 5 indexed citations
3.
Sanvisens, Arantza, et al.. (2023). Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994–2018). Cancer Medicine. 12(11). 12343–12353. 1 indexed citations
4.
Rubió‐Casadevall, Jordi, et al.. (2021). Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor. European Journal of Dermatology. 31(5). 616–622. 6 indexed citations
5.
Solans, Marta, Gemma Osca‐Gelis, R. Comas, et al.. (2018). Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain. Cancer Causes & Control. 29(3). 379–382. 8 indexed citations
6.
Solans, Marta, Laura Serra, Gemma Renart, et al.. (2017). Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study. European Journal of Cancer Prevention. 26. S164–S169. 5 indexed citations
7.
Rubió‐Casadevall, Jordi, et al.. (2016). Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study. Cancer Epidemiology. 45. 6–10. 42 indexed citations
8.
Osca‐Gelis, Gemma, et al.. (2014). Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study. Leukemia & lymphoma. 56(4). 896–902. 9 indexed citations
9.
Osca‐Gelis, Gemma, et al.. (2014). Proporción de cáncer de mama en mujeres de 50 a 69 años de Girona según el método de detección. Medicina Clínica. 143(7). 300–302. 1 indexed citations
10.
Sant, Milena, Pamela Minicozzi, Morgane Mounier, et al.. (2014). Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. The Lancet Oncology. 15(9). 931–942. 209 indexed citations
11.
Pérez-García, Arianne, Gemma Osca‐Gelis, Rocío Rodriguez, et al.. (2013). Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription. Human Immunology. 74(9). 1219–1224. 27 indexed citations
12.
Pollán, Marina, Montserrat Rué, Gemma Osca‐Gelis, et al.. (2012). Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983–2007. The Breast. 21(5). 646–651. 17 indexed citations
13.
Osca‐Gelis, Gemma, et al.. (2012). Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993–2007. Leukemia Research. 36(10). 1262–1266. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026